File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1159/000127212
- Scopus: eid_2-s2.0-0030915729
- PMID: 9258913
- WOS: WOS:A1997XL30000001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Gene expression of hypothalamic somatostatin and growth hormone-releasing hormone in dexamethasone-treated rats
Title | Gene expression of hypothalamic somatostatin and growth hormone-releasing hormone in dexamethasone-treated rats |
---|---|
Authors | |
Keywords | Adrenal steroids Growth hormone Growth hormone-releasing hormone Molecular neuroendocrinology Somatostatin |
Issue Date | 1997 |
Publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEN |
Citation | Neuroendocrinology, 1997, v. 66 n. 1, p. 2-8 How to Cite? |
Abstract | Supraphysiological doses of glucocorticoids inhibit growth hormone (GH) secretion in man and experimental animals. We investigated whether glucocorticoids inhibit GH secretion through changes in the gene expression of GH, hypothalamic somatostatin (SS) and GH-releasing hormone (GHRH), and whether such changes vary with the dose and duration of glucocorticoid excess. Male rats, 6 weeks of age, were treated with injections of either saline or different doses of dexamethasone (40, 200, 500 or 1000 μg/kg/day) intraperitoneally for 3 or 8 days. Total RNA extracted from the anterior pituitary and hypothalamus was analyzed by Northern blot hybridization. SS mRNA level was also assessed in smaller hypothalamic fragments containing predominantly the periventricular and paraventricular nuclei, and by in situ hybridization. A biphasic effect on SS mRNA levels was observed such that a significant increase (p < 0.001) was demonstrated in the periventricular nucleus after 3 days of dexamethasone 1000 μg/kg/day, but a reduction in hypothalamic SS mRNA was seen after 8 days for all doses employed (p < 0.05 or p < 0.01). On the other hand, hypothalamic GHRH mRNA levels showed a reduction which appeared to increase with the dose and duration of treatment and became statistically significant after 8 days at doses ≤ 200 μg/kg/day (p < 0.05). Pituitary GH mRNA levels were increased after 3 days at doses ≤ 500 μg/kg/day (p < 0.05) but showed no significant change at all doses after 8 days. We conclude that glucocorticold excess is associated with changes in the gene expression of GH, hypothalamic SS and GHRH, which vary with the dose and duration of glucocorticoid treatment. Glucocorticoids inhibit GH secretion in vivo through a reduction in hypothalamic GHRH gene expression and, in animals with shorter duration of glucocorticoid excess, also through an increase in SS gene expression in the periventricular nucleus. |
Persistent Identifier | http://hdl.handle.net/10722/148085 |
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 1.009 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lam, KSL | en_HK |
dc.contributor.author | Srivastava, G | en_HK |
dc.date.accessioned | 2012-05-29T06:10:45Z | - |
dc.date.available | 2012-05-29T06:10:45Z | - |
dc.date.issued | 1997 | en_HK |
dc.identifier.citation | Neuroendocrinology, 1997, v. 66 n. 1, p. 2-8 | en_HK |
dc.identifier.issn | 0028-3835 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/148085 | - |
dc.description.abstract | Supraphysiological doses of glucocorticoids inhibit growth hormone (GH) secretion in man and experimental animals. We investigated whether glucocorticoids inhibit GH secretion through changes in the gene expression of GH, hypothalamic somatostatin (SS) and GH-releasing hormone (GHRH), and whether such changes vary with the dose and duration of glucocorticoid excess. Male rats, 6 weeks of age, were treated with injections of either saline or different doses of dexamethasone (40, 200, 500 or 1000 μg/kg/day) intraperitoneally for 3 or 8 days. Total RNA extracted from the anterior pituitary and hypothalamus was analyzed by Northern blot hybridization. SS mRNA level was also assessed in smaller hypothalamic fragments containing predominantly the periventricular and paraventricular nuclei, and by in situ hybridization. A biphasic effect on SS mRNA levels was observed such that a significant increase (p < 0.001) was demonstrated in the periventricular nucleus after 3 days of dexamethasone 1000 μg/kg/day, but a reduction in hypothalamic SS mRNA was seen after 8 days for all doses employed (p < 0.05 or p < 0.01). On the other hand, hypothalamic GHRH mRNA levels showed a reduction which appeared to increase with the dose and duration of treatment and became statistically significant after 8 days at doses ≤ 200 μg/kg/day (p < 0.05). Pituitary GH mRNA levels were increased after 3 days at doses ≤ 500 μg/kg/day (p < 0.05) but showed no significant change at all doses after 8 days. We conclude that glucocorticold excess is associated with changes in the gene expression of GH, hypothalamic SS and GHRH, which vary with the dose and duration of glucocorticoid treatment. Glucocorticoids inhibit GH secretion in vivo through a reduction in hypothalamic GHRH gene expression and, in animals with shorter duration of glucocorticoid excess, also through an increase in SS gene expression in the periventricular nucleus. | en_HK |
dc.language | eng | en_US |
dc.publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEN | en_HK |
dc.relation.ispartof | Neuroendocrinology | en_HK |
dc.rights | Neuroendocrinology. Copyright © S Karger AG. | - |
dc.subject | Adrenal steroids | en_HK |
dc.subject | Growth hormone | en_HK |
dc.subject | Growth hormone-releasing hormone | en_HK |
dc.subject | Molecular neuroendocrinology | en_HK |
dc.subject | Somatostatin | en_HK |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Blotting, Northern | en_US |
dc.subject.mesh | Dexamethasone - Administration & Dosage - Pharmacology | en_US |
dc.subject.mesh | Gene Expression - Drug Effects | en_US |
dc.subject.mesh | Glucocorticoids - Pharmacology | en_US |
dc.subject.mesh | Growth Hormone - Blood - Genetics | en_US |
dc.subject.mesh | Growth Hormone-Releasing Hormone - Genetics | en_US |
dc.subject.mesh | Hypothalamus - Chemistry - Metabolism | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Pituitary Gland, Anterior - Chemistry | en_US |
dc.subject.mesh | Rna, Messenger - Analysis | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Sprague-Dawley | en_US |
dc.subject.mesh | Somatostatin - Genetics | en_US |
dc.title | Gene expression of hypothalamic somatostatin and growth hormone-releasing hormone in dexamethasone-treated rats | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Lam, KSL:ksllam@hku.hk | en_HK |
dc.identifier.email | Srivastava, G:gopesh@pathology.hku.hk | en_HK |
dc.identifier.authority | Lam, KSL=rp00343 | en_HK |
dc.identifier.authority | Srivastava, G=rp00365 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1159/000127212 | - |
dc.identifier.pmid | 9258913 | - |
dc.identifier.scopus | eid_2-s2.0-0030915729 | en_HK |
dc.identifier.hkuros | 33565 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0030915729&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 66 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 2 | en_HK |
dc.identifier.epage | 8 | en_HK |
dc.identifier.isi | WOS:A1997XL30000001 | - |
dc.publisher.place | Switzerland | en_HK |
dc.identifier.scopusauthorid | Lam, KSL=8082870600 | en_HK |
dc.identifier.scopusauthorid | Srivastava, G=7202242238 | en_HK |
dc.identifier.issnl | 0028-3835 | - |